Showing 541 - 560 results of 41,312 for search '(( significant ((force decrease) OR (fold decrease)) ) OR ( significant changes decrease ))', query time: 0.75s Refine Results
  1. 541
  2. 542

    Decreased CD28 signaling and activated CTLA-4 pathways during acute thymic atrophy. by Matthew J. Billard (227285)

    Published 2011
    “…CTLA-4, CD86 and CD80 mRNA levels were significantly increased while CD28 and TCR signaling-related mRNA levels were decreased. …”
  3. 543

    Force-pCa curves for the model and effects of changes in crossbridge affinity. by Sander Land (782066)

    Published 2015
    “…<p>The effects of crossbridge inhibition by substances such as blebbistatin and sodium vanadate were simulated by changing the dissociation constant of myosin (<i>K</i><sub>DM</sub>), resulting in significant changes in calcium sensitivity. …”
  4. 544
  5. 545
  6. 546
  7. 547
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552

    Fold change of differentially expressed genes relative to promoter methylation profile. by Iain Hartley (476957)

    Published 2013
    “…<p>Each point represents one gene with significant change in expression (p < 0.05) in addition to having at least two measured methylation sites within its promoter region. …”
  13. 553

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
  14. 554

    Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

    Published 2019
    “…(D) Schematic summary of CHX versus TBEV effect on the expression of POLR1 and POLR3 transcripts. (↓) indicates observed decrease of the RNA levels and (─) indicates no change in RNA levels.…”
  15. 555

    The <i>rcan-1</i> rearrangement allele decreases expression of <i>rcan-1</i>. by Yuehui Zhao (3146229)

    Published 2020
    “…The gene with the largest and most significant expression decrease was <i>rcan-1</i>. Red: p<0.01, log<sub>2</sub>(Fold Change) > 1. …”
  16. 556
  17. 557
  18. 558
  19. 559
  20. 560